These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models. Latta-Mahieu M; Elmer B; Bretteville A; Wang Y; Lopez-Grancha M; Goniot P; Moindrot N; Ferrari P; Blanc V; Schussler N; Brault E; Roudières V; Blanchard V; Yang ZY; Barneoud P; Bertrand P; Roucourt B; Carmans S; Bottelbergs A; Mertens L; Wintmolders C; Larsen P; Hersley C; McGathey T; Racke MM; Liu L; Lu J; O'Neill MJ; Riddell DR; Ebneth A; Nabel GJ; Pradier L Glia; 2018 Mar; 66(3):492-504. PubMed ID: 29134678 [TBL] [Abstract][Full Text] [Related]
6. [Alzheimer disease and immunotherapy: hope or disillusion?]. Dubois B Encephale; 2006 Sep; 32 Pt 5():S638-40. PubMed ID: 17099588 [No Abstract] [Full Text] [Related]
7. Mechanisms of A beta plaque clearance following passive A beta immunization. Morgan D Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007 [TBL] [Abstract][Full Text] [Related]
8. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075 [TBL] [Abstract][Full Text] [Related]
9. [The role of blood-brain barrier in the pathogenesis of Alzheimer dementia--implications for immunological therapies for plaque dissolution]. Pahnke J; Krohn M; Scheffler K Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S21-4. PubMed ID: 19685385 [TBL] [Abstract][Full Text] [Related]
10. [Current trend of immunotherapy for Alzheimer's disease]. Matsumoto SE; Tabira T Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765 [TBL] [Abstract][Full Text] [Related]
11. Comment on Vandal et al. Insulin Reverses the High-Fat Diet-Induced Increase in Brain Aβ and Improves Memory in an Animal Model of Alzheimer Disease. Diabetes 2014;63:4291-4301. Ghanim H; Dandona P Diabetes; 2015 Jul; 64(7):e17. PubMed ID: 26106201 [No Abstract] [Full Text] [Related]
12. Response to Comment on Vandal et al. Insulin Reverses the High-Fat Diet-Induced Increase in Brain Aβ and Improves Memory in an Animal Model of Alzheimer Disease. Diabetes 2014;63:4291-4301. Vandal M; Calon F Diabetes; 2015 Jul; 64(7):e18. PubMed ID: 26106202 [No Abstract] [Full Text] [Related]
13. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease. Solomon B Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423 [TBL] [Abstract][Full Text] [Related]
14. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice. Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784 [TBL] [Abstract][Full Text] [Related]
16. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL; Tung YC; Liu F; Gong CX; Iqbal K Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379 [TBL] [Abstract][Full Text] [Related]
17. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer. Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339 [TBL] [Abstract][Full Text] [Related]
18. Active immunotherapy facilitates Aβ plaque removal following through microglial activation without obvious T cells infiltrating the CNS. Sha S; Xing XN; Cao YP J Neuroimmunol; 2014 Sep; 274(1-2):62-70. PubMed ID: 25087756 [TBL] [Abstract][Full Text] [Related]